These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Marked response to oral administration of UFT and leucovorin for liver metastases from colon cancer in an elderly patient].
    Author: Teraishi F, Ozaki K, Shibuya Y, Shima Y, Nakamura T, Hamada M, Fukui Y, Nishioka Y, Horimi T, Uchida Y.
    Journal: Gan To Kagaku Ryoho; 2012 Mar; 39(3):473-5. PubMed ID: 22421783.
    Abstract:
    A83 -year-old man was admitted to our hospital for the treatment of advanced ascending colon cancer with liver metastases. He had initially undergone an ileocecal resection for ascending colon cancer. Subsequently, we started oral administration of UFT/LV(UFT 400mg/day, LV 75 mg/day, and 4 weeks of therapy followed by a week suspension of treatment). After 3 courses, his tumors responded well to treatment, and CT showed marked regression of liver metastases. After 10 courses, liver metastases had almost disappeared. Two years passed without any adverse events since UFT/LV therapy was started. These findings suggest that UFT/LV therapy is very safe and effective for elderly patients with unresectable colorectal cancer.
    [Abstract] [Full Text] [Related] [New Search]